Corporate ActionAug 3, 2026, 09:03 AM
Sunshine Biopharma Series B Warrant Price Reduced to $1.2202
AI Summary
Sunshine Biopharma Inc. announced that the exercise price of its outstanding Series B Warrants has been reduced to $1.2202. This adjustment is a result of recent sales of the company's common stock under its previously disclosed at-the-market offering. The exercise price remains subject to further adjustments as outlined in the Series B Warrants.
Key Highlights
- Series B Warrant exercise price reduced to $1.2202.
- Reduction triggered by recent common stock sales via at-the-market offering.
- Exercise price remains subject to further adjustments.
Price Impact
More from SBFM